[1]张 冰,张丽娜,尚琳琳.滋阴益肾法治疗特发性血小板减少性紫癜疗效及对患者血清IL-4、IL-6和免疫功能的影响*[J].陕西中医,2020,(2):194-197.
　ZHANG Bing,ZHANG Lina,SHANG Linlin..Therapeutic effect of Ziyin Yishen therapy on idiopathic thrombocytopenic purpura and its effects on serum IL-4,IL-6 and immune function in patients with idiopathic thrombocytopenic purpura[J].,2020,(2):194-197.
点击复制

滋阴益肾法治疗特发性血小板减少性紫癜疗效及对患者血清IL-4、IL-6和免疫功能的影响*
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2020年2期
页码:
194-197
栏目:
临床研究
出版日期:
2020-02-05

文章信息/Info

Title:
Therapeutic effect of Ziyin Yishen therapy on idiopathic thrombocytopenic purpura and its effects on serum IL-4,IL-6 and immune function in patients with idiopathic thrombocytopenic purpura
文章编号:
DOI:〖HT5K〗10.3969/j.issn.10007369.2020.02.015
作者:
张 冰; 张丽娜; 尚琳琳
河南省漯河市中医院(漯河 462000)
Author(s):
ZHANG Bing; ZHANG Lina; SHANG Linlin.
Luohe Hospital of Traditional Chinese Medicine in Henan Province(Luohe 462000)
关键词:
滋阴益肾法;  特发性血小板减少性紫癜;  血清炎性因子;  T淋巴细胞亚群;  临床疗效
Keywords:
Ziyin Yishen therapy;  Idiopathic thrombocytopenic purpura;  Serum inflammatory factors;  T lymphocyte subsets;  Clinical efficacy
分类号:
R554.6
文献标志码:
A
摘要:
目的: 探讨滋阴益肾法治疗特发性血小板减少性紫癜(ITP)的疗效及对血清IL-4、IL-6、TNF-α及免疫功能的影响。方法:选取ITP患者84例,随机数字表法分为对照组和观察组,各42例。对照组采用口服泼尼松片治疗,观察组在对照组用药基础上给予滋阴益肾法治疗。比较两组临床疗效,治疗前后IL-4、IL-6、TNF-α、外周血T淋巴细胞亚群(CD3+、CD4+、CD8+、CD4+ /CD8+)及免疫球蛋白水平变化情况。结果:两组治疗后中医症候积分明显降低,观察组优于对照组(P<0.05)。观察组总有效率95.24%高于对照组78.57%(P<0.05); 两组治疗后PLT计数均明显升高、PAIgG表达水平降低,观察组更明显(P<0.05); 两组治疗前IL-4、IL-6、TNF-α及外周血T淋巴细胞亚群水平比较差异无统计学意义(P>0.05); 治疗后CD3+、CD4+、CD4+ /CD8+均升高,IL-4、IL-6、TNF-α、CD8+均降低(P<0.05); 观察组治疗后CD3+、CD4+、CD4+ /CD8+均高于对照组,IL-4、IL-6、TNF-α、CD8+均低于对照组(P<0.05)。治疗后观察组的血清IgA和IgG水平明显高于对照组(P<0.05),而血清IgM水平差异无统计学意义(P>0.05)。两组不良反应情况比较无统计学差异(P>0.05)。结论: 滋阴益肾法可显著降低ITP患者血清IL-4、IL-6等因子水平,提高患者免疫能力。
Abstract:
Objective:To investigate the therapeutic effect of Ziyin Yishen therapy on idiopathic thrombocytopenic purpura(ITP)and its effects on serum IL-4,IL-6,TNF-alpha and immune function.Methods:84 ITP patients were divided into control group and observation group by random number method,42 cases in each group.The control group was treated with oral prednisone tablets,while the observation group was treated with Ziyin Yishen therapy on the basis of the control group.The clinical effects of the two groups were compared.The levels of IL-4,IL-6,TNF-alpha and T lymphocyte subsets(CD3+,CD4+,CD8+,CD4+/CD8+)in peripheral blood were measured before and after treatment.Results: After treatment,the scores of TCM symptoms in the two groups were significantly reduced,and the observation group was better than the control group(P<0.05).The total effective rate of the observation group was 95.24% higher than that of the control group(78.57%,P<0.05).After treatment,PLT counts increased significantly and PAIgG expression decreased in both groups,especially in the observation group(P<0.05).There was no significant difference in the levels of IL-4,IL-6,TNF-alpha and T lymphocyte subsets in peripheral blood between the two groups before treatment(P>0.05).CD4+/CD8+ increased,IL-4,IL-6,TNF-alpha and CD8+ decreased(P<0.05); after treatment,CD3+,CD4+,CD4+/CD8+ in the observation group were higher than those in the control group,and IL-4,IL-6,TNF-alpha and CD8+ were lower than those in the control group(P<0.05).After treatment,the serum IgA and IgG levels in the observation group were significantly higher than those in the control group(P<0.05),but there was no significant difference in serum IgM levels(P>0.05).There was no significant difference in adverse reactions between the two groups(P>0.05).Conclusion:Ziyin Yishen therapy can significantly reduce the level of serum IL-4,IL-6 and other factors in ITP patients,and improve the immune ability of patients.

参考文献/References:

[1] 滕 志,雷 秦,许世娟,等.利妥昔单抗治疗难治性特发性血小板减少性紫癜患者临床研究[J].陕西医学杂志,2019,48(1):104-106.
[2] 张雪梅.探析静脉输注入血丙种球蛋白联合地塞米松治疗小儿特发性血小板减少性紫癜(ITP)的疗效[J].临床医药文献电子杂志,2017,4(1):177-178.
[3] 吕 艳,刘文文,王 聪,等.特发性血小板减少性紫癜患者T细胞及B细胞亚群变化的研究[J].国际免疫学杂志,2017,40(1):21-25.
[4] 邹志宁.补中益气法联合泼尼松对慢性型特发性血小板减少性紫癜患者血小板数量的临床干预研究[J].中国当代医药,2017,24(23):136-138.
[5] 赵 瑞,刘 瑜,卢远强,等.中药治疗特发性血小板减少性紫癜临床观察[J].实用中医药杂志,2018,34(3):282-283.
[6] 张之南.血液病诊断及疗效标准[M].北京:科学出版社,2007:172-175.
[7] 朱建军,王 缨.柴胡皂苷d对激素抵抗型特发性血小板减少性紫癜的调控作用[J].中医学报,2017,32(1):117-119.
[8] 李 林,胡 军,谭 潇,等.B细胞刺激因子及其特异性受体在ITP发病机制中的研究进展[J].重庆医学,2018,47(27):87-89.
[9] 高凤艳,郝国平.急慢性ITP患儿外周血调节性T细胞及相关细胞因子的表达及意义[J].临床医药实践,2017,26(7):493-497.
[10] 连粉红,刘守海,郭炳涛,等.夏小军主任医师采用“治血四法”治疗特发性血小板减少性紫癜经验[J].中医研究,2017,30(10):33-36.
[11] 钟新林,蔡江龙,杨立芳,等.健脾生血汤治疗气不摄血型慢性特发性血小板减少性紫癜的临床研究[J].湖南中医药大学学报,2019,39(1):105-109.
[12] 陈治峰,王 丽,杜 娟, 等.益气化斑方治疗过敏性紫癜疗效及对患儿Gd-IgA1、NF-κB水平的影响[J].陕西中医,2019,40(2):237-240.
[13] 岳红梅,黄子亮,薛祥俊, 等.中药治疗特发性血小板减少性紫癜临床观察[J].深圳中西医结合杂志,2018,28(23):67-69.
[14] 李 琳,丁云录,张莲珠, 等.补气养阴颗粒对特发性血小板减少性紫癜模型小鼠淋巴细胞亚群的影响[J].中国老年学杂志,2018,38(21):5297-5299.
[15] 李庆珍,宋卫国.滋阴补肾化瘀法联合中药熏蒸治疗高血压肾损害的临床研究[J].中国当代医药,2017,24(34):151-153.
[16] 刘 杰.孟鲁司特联合山莨菪碱治疗儿童过敏性紫癜疗效观察[J].陕西医学杂志,2017,46(2):265-266.
[17] 王冠涛.特发性血小板减少性紫癜的中医治疗体会[J].中国保健营养,2019,29(23):346.
[18] 马礼勇.美罗华联合地塞米松治疗难治性特发性血小板减少性紫癜的临床效果分析[J].中外医疗,2019,38(22):79-81.
[19] 王 莹,王晓琴,宋爱琴,等.特发性血小板减少性紫瘢患儿T细胞亚群、NK细胞及细胞因子变化及意义[J].中国临床医生杂志,2018,46(2):178-180.
[20] 陈 丽.前驱疱疹病毒感染对特发性血小板减少性紫癜患儿细胞免疫功能及一线药物治疗效果的影响[J].抗感染药学,2017,12(4):48-50.
[21] 徐 旻,沈 伟.补肾填髓活血方对慢性特发性血小板减少性紫癜患者T细胞亚群的影响[J].陕西中医,2010,31(6):680-681.

备注/Memo

备注/Memo:
*河南省中医药科学研究专项课题(2015ZY02122)
更新日期/Last Update: 2020-03-31